Leucadia National - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Leucadia National ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,102,37338,8570.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 4,780,188$353,877,00083.76%
JW Asset Management, LLC 848,709$62,830,00022.76%
Consonance Capital Management LP 1,353,913$100,230,00014.10%
Cormorant Asset Management, LP 300,000$22,209,0003.55%
Park West Asset Management LLC 500,591$37,059,0003.38%
Opaleye Management Inc. 73,200$5,419,0002.67%
Ranger Investment Management 428,295$31,707,0001.79%
WALL STREET ASSOCIATES 119,900$8,876,0001.70%
Timpani Capital Management LLC 27,090$2,005,0000.81%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 22,375$1,656,0000.79%
View complete list of EAGLE PHARMACEUTICALS INC shareholders